Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Angina Pectoris D000787 27 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Arch Syndromes D001015 2 associated lipids
Aortic Rupture D001019 3 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ahlsten G et al. Aggregation of and thromboxane B2 synthesis in platelets from newborn infants of smoking and non-smoking mothers. 1985 Prostaglandins Leukot Med pmid:3863152
Rosenkranz B and Frölich JC Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid. 1985 Prostaglandins Leukot Med pmid:3864170
Greer IA et al. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. 1985 Thromb. Haemost. pmid:2867620
Patrassi GM et al. Contact phase of coagulation in diabetes mellitus after aspirin administration. 1985 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2410343
Safai-Kutti S et al. Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients. 1985 Eur. Heart J. pmid:2412820
Demling RH et al. Early lung dysfunction after major burns: role of edema and vasoactive mediators. 1985 J Trauma pmid:2413227
Myśliwiec M et al. Plasma thromboxane B2 in haemodialysed patients. 1985 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2414174
Luzzatto G et al. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders. 1985 Scand J Haematol pmid:2414843
Yajima M et al. Plasma thromboxane B2, 6-keto PGF1 alpha and cyclic nucleotides levels as related to treadmill exercise test in patients with ischemic heart disease. 1985 Jpn. Circ. J. pmid:2982050
Schlondorff D and Satriano JA Interactions of vasopressin, cAMP, and prostaglandins in toad urinary bladder. 1985 Am. J. Physiol. pmid:2579584
Francos GC et al. Dialysis-induced hypoxemia: membrane dependent and membrane independent causes. 1985 Am. J. Kidney Dis. pmid:3919574
Kobayashi H et al. Effects of 6-keto-prostaglandin E1 on ascitic hepatoma-130 in vivo comparison with chemotherapeutic agents. 1985 Prostaglandins pmid:3920729
Powell AM et al. Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea. 1985 Prostaglandins pmid:3856904
Ylitalo P et al. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol. 1985 Clin. Pharmacol. Ther. pmid:3899459
Glance DG et al. Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledon. 1985 Am. J. Obstet. Gynecol. pmid:3855602
Gorczynska E et al. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro]. 1985 Wiad. Lek. pmid:3933184
Berman B et al. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells. 1985 J. Invest. Dermatol. pmid:2578172
Shayevitz JR et al. Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect. 1985 Anesthesiology pmid:3933385
Patrono C et al. Clinical pharmacology of platelet cyclooxygenase inhibition. 1985 Circulation pmid:3933848
VanRollins M et al. Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets. 1985 Biochim. Biophys. Acta pmid:3918572
Gee MH et al. Eicosanoids, leukocytes and lung injury. 1985 Prog. Clin. Biol. Res. pmid:3934681
Leslie JB and Watkins WD Eicosanoids in the central nervous system. 1985 J. Neurosurg. pmid:2997413
Darius H et al. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. 1985 J. Pharmacol. Exp. Ther. pmid:2997428
Zavagli G et al. Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatment. 1985 Prostaglandins Leukot Med pmid:2997804
Shono F et al. A solid-phase enzyme immunoassay of thromboxane B2. 1985 J. Biochem. pmid:3935648
Sinzinger H Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers. 1985 Eur. J. Clin. Pharmacol. pmid:2998802
Greer IA et al. Platelet activation in allergic asthma. 1985 Thromb. Haemost. pmid:2931855
Safai-Kutti S et al. Impaired in vivo platelet reactivity in infantile autism. 1985 Acta Paediatr Scand pmid:2931944
Mikhailidis DP et al. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. 1985 Eur. J. Clin. Invest. pmid:3938401
Meese CO et al. Measurement of thromboxane B2 in human urine by isotope dilution and negative ion chemical ionization mass spectrometry. 1985 Biomed. Mass Spectrom. pmid:2932184
Boss AH et al. Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease. 1985 Eur. J. Clin. Invest. pmid:3938412
Ambler J et al. CGS 12970: a novel, long acting thromboxane synthetase inhibitor. 1985 Br. J. Pharmacol. pmid:2932197
Gresele P et al. Thromboxane A2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans. 1985 J. Lab. Clin. Med. pmid:2932514
Schambelan M et al. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. 1985 J. Clin. Invest. pmid:3156147
Mueller HS et al. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin. 1985 Circulation pmid:2933181
Hakim RM and Schafer AI Hemodialysis-associated platelet activation and thrombocytopenia. 1985 Am. J. Med. pmid:3885730
Howes EL et al. Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects. 1985 Arch. Ophthalmol. pmid:3156578
Velardo B and Lagarde M Differential effect of external calcium on the oxygenated metabolism of endogenous and exogenous arachidonic acid in platelets. 1985 Biochem. Biophys. Res. Commun. pmid:3927915
Schafer AI and Adelman B Plasmin inhibition of platelet function and of arachidonic acid metabolism. 1985 J. Clin. Invest. pmid:3156149
Klotman PE et al. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats. 1985 Kidney Int. pmid:2422431
Neri Serneri GG et al. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. 1985 Am. Heart J. pmid:3984828
Vesterqvist O et al. In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. 1985 Thromb. Res. pmid:3992528
Wirthumer-Hoche C and Sinzinger H [Protein binding of thromboxane--one of the sources of error in thromboxane determination]. 1985 Wien. Klin. Wochenschr. pmid:3993037
Croft KD et al. Onset of changes in phospholipid fatty acid composition and prostaglandin synthesis following dietary manipulation with n-6 and n-3 fatty acids in the rat. 1985 Biochim. Biophys. Acta pmid:3995069
Eldor A et al. Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction. 1985 Blood pmid:3995180
Mayfield RK et al. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. 1985 Diabetes pmid:3930325
Moncada S and Whittle BJ Biological actions of prostacyclin and its pharmacological use in platelet studies. 1985 Adv. Exp. Med. Biol. pmid:3010671
Preud'homme Y et al. Metabolism of arachidonic acid in rabbit iris and retina. 1985 Invest. Ophthalmol. Vis. Sci. pmid:3930417
Roy L et al. Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease. 1985 Am. Heart J. pmid:3158183
Pedrinelli R et al. The influence of selective and nonselective prostaglandin inhibition on renin. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159197
Ezra D et al. Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159202
Gensini GF et al. Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159209
De Caterina R et al. Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159210
Trimarco B et al. Indomethacin blunts the late phase of nitroglycerin-induced coronary vasodilatation in dogs. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159220
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Shikano M et al. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159226
Kelley VE et al. A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. 1985 J. Immunol. pmid:3918111
Prosdocimi M et al. Prostacyclin and thromboxane levels during cardiac ischemia in dogs. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159235
Stine RA et al. Failure of percutaneous transluminal coronary angioplasty to stimulate platelet and prostaglandin activity. 1985 Cathet Cardiovasc Diagn pmid:3160477
Valentovic MA and Lubawy WC Elevated glucose in vivo and in vitro adversely alters prostaglandin generation in rat aortas and platelets. 1985 Prostaglandins Leukot Med pmid:3903777
Liu MC et al. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases. III. Platelet hyperactivation in the chronic phase of cerebral thromboembolism. 1985 Taiwan Yi Xue Hui Za Zhi pmid:3160819
Hechtman DH and Jageneau A Inhibition of cold-induced vasoconstriction with ketanserin. 1985 Microvasc. Res. pmid:3160915
Petroni A et al. Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain. 1985 Prostaglandins pmid:3839085
Zipser RD Effects of selective inhibition of thromboxane synthesis on renal function in humans. 1985 Am. J. Physiol. pmid:3839111
Elliott GR et al. Differential regulation of the cyclooxygenase pathway in starch elicited rat peritoneal macrophages by prostaglandin E2, U-44069, a stable endoperoxide analogue and dibutyryl-cyclic AMP. 1985 Eur. J. Pharmacol. pmid:2995076
Weisman SM et al. Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. 1985 J. Pharmacol. Exp. Ther. pmid:3862805
Fink MP et al. Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofen. 1985 J. Surg. Res. pmid:3839278
Bornman MS et al. Elevated thromboxane B2 levels during erection. 1985 S. Afr. Med. J. pmid:3839322
Galli C et al. Modification of brain vascular eicosanoids after pharmacological treatment and ischemia in the rat: drugs and brain vascular eicosanoids. 1985 Cephalalgia pmid:3839438
Casey LC et al. The role of thromboxane in primate endotoxin shock. 1985 J. Surg. Res. pmid:3839548
Jindal SK et al. Regulation of increase in anastomotic blood flow following pulmonary arterial occlusion. 1985 J. Appl. Physiol. pmid:3839787
Narita H et al. Insufficient mobilization of calcium by early breakdown of phosphatidylinositol 4,5-bisphosphate for aggregation of human platelets by collagen. 1985 J. Biochem. pmid:3001036
Garrett RC and Thomas HM Relation of prostanoids to strength of hypoxic vasoconstriction in dogs with lobar atelectasis. 1985 J. Appl. Physiol. pmid:3839788
Horiuchi Y et al. [Studies on changes in histamine levels in the blood of infants and children. Part 7. The time studies of histamine, lipoxygenase metabolites, thromboxe B2 and cyclic AMP release from human platelets and leucocytes on treadmill exercise in asthmatic children]. 1985 Arerugi pmid:3002304
Giani E et al. Heated fat, vitamin E and vascular eicosanoids. 1985 Lipids pmid:3839887
Sylvester JT et al. Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. 1985 Chest pmid:3840073
Steinhauer HB et al. Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. 1985 Eur. J. Clin. Invest. pmid:3921379
Kimura Y et al. Effects of stilbene derivatives on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3931689
DiMinno G et al. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. 1985 Blood pmid:2981130
Gairola C and Tai HH Selective inhibition of leukotriene B4 biosynthesis in rat pulmonary alveolar macrophages by dietary selenium deficiency. 1985 Biochem. Biophys. Res. Commun. pmid:2998361
Leffler CW and Busija DW Prostanoids in cortical subarachnoid cerebrospinal fluid and pial arterial diameter in newborn pigs. 1985 Circ. Res. pmid:4053302
Ment LR et al. Beagle puppy model of perinatal cerebral infarction. Acute changes in regional cerebral prostaglandins during hemorrhagic hypotension. 1985 J. Neurosurg. pmid:4056903
Wong C et al. Effect of hydroxyl radical scavenging on endotoxin-induced lung injury. 1985 Surgery pmid:2983450
Di Minno G et al. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. 1985 Am. J. Med. pmid:3933340
Katoh K et al. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor]. 1985 Masui pmid:4057547
Jackson EK Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery. 1985 J. Clin. Invest. pmid:4077980
Dempsey RJ et al. Polyamine and prostaglandin markers in focal cerebral ischemia. 1985 Neurosurgery pmid:3864030
Dahl ML and Uotila P Sodium salicylate does not prevent the inhibitory effect of indomethacin on thromboxane formation in human blood ex vivo. 1985 Prostaglandins Leukot Med pmid:3856282
De Caterina R et al. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction. 1985 Thromb. Haemost. pmid:4082090
Kääpä P Immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in neonatal hyperbilirubinemia. 1985 Prostaglandins Leukot Med pmid:3856285
Delvos U et al. Direct radioimmunological measurement of thromboxane B2 in plasma. 1985 Thromb. Res. pmid:4082109
Semrad SD et al. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. 1985 Am. J. Vet. Res. pmid:4083579
Mallarkey G and Smith GM A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats. 1985 Br. J. Pharmacol. pmid:3156648
Ding YA et al. Potentiation of adrenaline-induced platelet aggregation by angiotensin II. 1985 Thromb. Haemost. pmid:4089801
Lawson JA et al. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry. 1985 Anal. Biochem. pmid:4091270
Zijlstra FJ and Vincent JE Leukotriene D4 and phospholipase A2 release thromboxane A2 of different origin in the guinea pig lung parenchymal strip. 1985 Prostaglandins Leukot Med pmid:3857642
Salmon JA et al. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase. 1985 Prostaglandins pmid:2988019
Hutchison AA et al. Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates. 1985 Prostaglandins Leukot Med pmid:3859877
Reines HD et al. Lack of effect of glucocorticoids upon plasma thromboxane in patients in a state of shock. 1985 Surg Gynecol Obstet pmid:3983796
Singer P et al. Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. 1985 Atherosclerosis pmid:3000395